Moderna Inc Vaccines Day Transcript
Good morning, and welcome to Moderna's Third Annual Vaccines Day. Today, you will be hearing from our scientists and program leaders present data from our mRNA vaccines programs. You will also hear from distinguished key opinion leaders in Immunology and Vaccinology as it relates to SARS-CoV-2, influenza and latent viruses, including the association of EBV and multiple sclerosis.
Following the formal presentations, we will take your questions during the Q&A section. You can access the press release issued this morning as well as the presentation slides by going to the Investors section of our website. On today's call are Stephane Bancel, our Chief Executive Officer; Stephen Hoge, our President; Jacqueline Miller, Senior Vice President and Head of Infectious Diseases at Moderna; Raffael Nachbagauer, Program Leader for influenza vaccines; and Sumana Chandramouli, Program Lead for EBV vaccines.
Before we begin, please note that today's presentation will include forward-looking statements made pursuant to the safe harbor
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |